Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | Radiosensitizers to increase radiotherapy efficacy

Ananya Choudhury • 2 Jun 2019
ASCO 2019
Bladder Cancer Genitourinary Cancer Cisplatin Gemcitabine Nicotinamide
BC2001 BCON

Ananya Choudhury, PhD, MRCP, FRCR, of The Christie NHS Foundation Trust, Manchester, UK, presents data from clinical trials, where radiosensitizers increase the efficacy of radiotherapy in patients with bladder carcinoma. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

More from Ananya Choudhury

1:26
Personalized treatments in bladder cancers: future remarks
Ananya Choudhury • 2 Jun 2019
1:02
Rare urothelial cancers: what options are available?
Ananya Choudhury • 2 Jun 2019

Related Videos

4:05
Evaluating triplet therapy in metastatic hormone sensitive prostate cancer
Nick James • 24 Apr 2024
10:42
Management of prostate cancer from the patient perspective
David Matheson • 11 Apr 2024
2:26
Prognostic factors of renal cell cancer in elderly patients
Teemu Murtola • 9 Apr 2024
2:44
The effect of hypoxia on lipid metabolism and prostate cancer tumor growth
Teemu Murtola • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals